JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, S.-Y.
Right arrow Articles by Wang, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S.-Y.
Right arrow Articles by Wang, J.-J.

Anesth Analg 2005;101:785-792
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ane.0000166978.12457.7a


PAIN MEDICINE

Novel Depots of Ketorolac Esters Have Long-Acting Antinociceptive and Antiinflammatory Effects

Shyun-Yeu Liu, DDS*{dagger}{ddagger}, Ja-Ping Shieh, MD, MS{ddagger}, Jann-Inn Tzeng, MD, MS{ddagger}, Hou Chia-Hui, BS{ddagger}, Yen-Ling Cheng, BS{ddagger}, Kuo-Lun Huang, MS{ddagger}, and Jhi-Joung Wang, MD, PhD{ddagger}

*Department of Oral and Maxillofacial Surgery, National Defense Medical Center, Taipei; {dagger}Department of Oral and Maxillofacial Surgery, Taipei Medical University, Taipei; and {ddagger}Departments of Anesthesiology and Medical Research, Chi-Mei Medical Center, Tainan (Yung-Kang and Liou-Ying), Taiwan

Address correspondence and reprint requests to Jhi-Joung Wang, MD, PhD, Departments of Anesthesiology and Medical Research, Chi-Mei Medical Center, Tainan, Taiwan. Address e-mail to 400002{at}mail.chimei.org.tw.

No long-acting nonsteroidal antiinflammatory drug is clinically available for the treatment of pain. In this study, we evaluated the antinociceptive and antiinflammatory effects and duration of action of several novel depots of ketorolac esters, such as ketorolac propyl ester, pentyl ester, heptyl ester, and decyl ester, and observed whether they had a long-acting effect. Four studies in Sprague-Dawley rats were performed. In Studies 1–3, the antinociceptive and antiinflammatory effects of IM ketorolac tromethamine and its base and propyl ester were evaluated. In Study 4, the antinociceptive and antiinflammatory effects of several other ketorolac esters were evaluated. We found that ketorolac tromethamine 24, 80, and 240 µmol/kg (in saline) produced significant antinociceptive and antiinflammatory effects with duration of action of approximately 6–8 h. The four ketorolac esters at a dose of 240 µmol/kg (in oil) produced significant long-acting antinociceptive and antiinflammatory effects, with duration of action of approximately 52–76 h. We concluded that IM injection of novel depots of ketorolac esters in rats produce long-acting antinociceptive and antiinflammatory effects that are 6.5- to 9.5-fold longer than the traditional dosage form of ketorolac tromethamine.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2005 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.